MedTrace Logo

A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA

NCT07362667 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2026-01-23

No results posted yet for this study

Summary

To evaluate the efficacy and safety of bronchoscopic airway clearance and amphotericin B spraying in the treatment of allergic bronchopulmonary aspergillosis

Conditions

  • ABPA
  • Allergic Bronchopulmonary Aspergillosis
  • Allergic Bronchopulmonary Aspergillosis (ABPA)
  • Airway Clearance
  • Mucus Plug
  • Amphotericin B
  • Bronchoscope

Interventions

PROCEDURE

The patients were treated with bronchoscopic airway clearance and amphotericin B spraying

In addition to standard medical therapy (oral glucocorticoids with or without oral antifungal agents), bronchoscopic airway clearance and bronchoscopic spraying of amphotericin B (depending on the effectiveness of bronchoscopic mucus plug removal, At least one time of bronchoscopic airway clearance and amphotericin B spraying). The previous treatment for bronchial asthma was maintained, including inhaled corticosteroids + long-acting β-receptor agonists, leukotriene receptor antagonists, etc.

Sponsors & Collaborators

  • Qianfoshan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-10
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07362667 on ClinicalTrials.gov